My watch list
my.bionity.com  
Login  

23 Current news of Medicago

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Medicago to build $245M production facility in Quebec City

New complex will make vaccines and therapeutics using innovative plant technology

21-May-2015

Medicago announced that Quebec City will be home to its new production complex. The $245 million project will create 200 new high-skilled jobs by 2019, adding to the team of 180 employees already working at Medicago's Quebec City office and laboratories. The project is expected to generate more ...

more

Medicago and Cellectis Enter into Research Agreement to Improve Therapeutic Proteins Using Nuclease Technology

18-Jan-2012

Medicago Inc. and Cellectis plant sciences, a subsidiary of Cellectis SA announced the signing of a research agreement under which Medicago and Cellectis will collaborate to improve therapeutic proteins expressed from tobacco leaves. "We look forward to working with Cellectis plant sciences to ...

more

Medicago announces research collaboration for the development of a non-influenza vaccine candidate

12-Apr-2011

Medicago Inc. announced that it has entered into a research collaboration agreement for the development of a non-influenza vaccine candidate with a top 10 global pharmaceutical company.Under the terms of the research collaboration, Medicago will apply its transient expression system to develop a ...

more

Medicago announces an extension of its agreement with Genopole biopark

29-Nov-2010

Medicago Inc. announced an extension to its partnering agreement of July 2009 with Genopole®. Medicago and Genopole® will also work towards the creation a laboratory for research on vaccine and antibody targets of interest for France in terms of public health and biodefense. This laboratory is ...

more

Medicago discovers breakthrough method of preparing plant derived recombinant proteins and VLPs

27-Sep-2010

Medicago Inc. announced it has filed two international patent applications under the Patent Cooperation Treaty (PCT) that broadly cover new methods of preparing plant-derived recombinant proteins and VLPs. "The extraction and purification of recombinant proteins and complex structures such as ...

more

Medicago awarded $21 million from the U.S. Department of Defense

Medicago to develop a vaccine facility in Research Triangle Park, North Carolina

12-Aug-2010

Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency (DARPA), Broad Agency Announcement (BAA), Defense Sciences Research & Technology to demonstrate the scalable manufacturing of ...

more

Medicago signs MOU with NITT Partners for commercial development of influenza vaccines in Japan

19-Mar-2010

Medicago Inc. announced that it has signed a Memorandum of Understanding with Niigata TLO/NBRP/KUTLO-NITT ("NITT Partners") to discuss and negotiate an agreement to commercialize Medicago's pandemic and seasonal influenza VLP-based vaccines in Japan and other territories. For several years, NITT ...

more

Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy

13-Oct-2009

Medicago Inc. announced that it has been awarded a proof of concept contract by the U.S. Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Center ("ECBC") Research & Technology Directorate. Medicago will work with ECBC to investigate the ...

more

Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine

27-Aug-2009

Medicago Inc. announced that it has received clearance from Health Canada to commence a Phase I human clinical trial with its H5N1 Avian Influenza vaccine. Enrollment of volunteers is now underway. The Phase I placebo-controlled, double-blind, dose-escalating study will evaluate safety, ...

more

Medicago signs MOU with Ajanta Pharma for commercial development of influenza vaccines in India and other territories

25-Aug-2009

Medicago Inc. announced that it has signed a Memorandum of Understanding ("MOU") with Ajanta Pharma Limited to discuss and negotiate an agreement to commercialize Medicago's pandemic and seasonal influenza VLP-based vaccines in India and other territories. Under the terms of the MOU, the parties ...

more

Page 1 From 3
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE